Loading...
Docoh

Balchem (BCPC)

Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.

Company profile

Ticker
BCPC
Exchange
Website
CEO
Theodore Harris
Employees
Incorporated
Location
Fiscal year end
SEC CIK
Subsidiaries
BCP Ingredients, Inc. • Balchem BV • Balchem Italia Srl • Balchem Ltd. • Aberco, Inc. • SensoryEffects, Inc. • SensoryEffects Cereal Systems, Inc. • Albion Laboratories, Inc. • Balchem NV • Balchem Sdn Bhd ...
IRS number
132578432

BCPC stock data

Analyst ratings and price targets

Last 3 months

Calendar

29 Apr 22
2 Jul 22
31 Dec 22
Quarter (USD) Mar 22 Dec 21 Sep 21 Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 64.47M 64.47M 64.47M 64.47M 64.47M 64.47M
Cash burn (monthly) 12.92M 2.01M (no burn) (no burn) (no burn) (no burn)
Cash used (since last report) 39.63M 6.15M n/a n/a n/a n/a
Cash remaining 24.83M 58.32M n/a n/a n/a n/a
Runway (months of cash) 1.9 29.1 n/a n/a n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
15 Feb 22 John Y Televantos Common Stock Payment of exercise Dispose F No No 139.38 359 50.04K 28,806
15 Feb 22 Theodore L Harris Common Stock Payment of exercise Dispose F No No 139.38 2,400 334.51K 71,558
15 Feb 22 William A. Backus Common Stock Payment of exercise Dispose F No No 139.38 470 65.51K 9,786
15 Feb 22 Mark A Stach Common Stock Payment of exercise Dispose F No No 139.38 302 42.09K 7,763
15 Feb 22 James C Hyde Common Stock Payment of exercise Dispose F No No 139.38 348 48.5K 15,915
87.5% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 291 289 +0.7%
Opened positions 37 50 -26.0%
Closed positions 35 23 +52.2%
Increased positions 97 94 +3.2%
Reduced positions 106 95 +11.6%
13F shares Current Prev Q Change
Total value 3.81B 5.48B -30.5%
Total shares 28.12M 31.53M -10.8%
Total puts 11.2K 800 +1300.0%
Total calls 33.6K 110.7K -69.6%
Total put/call ratio 0.3 0.0 +4512.5%
Largest owners Shares Value Change
BLK Blackrock 4.89M $668.6M +1.0%
Vanguard 3.52M $481.54M -5.9%
APG Asset Management 2.72M $333.56M 0.0%
Wasatch Advisors 1.5M $204.94M -11.5%
STT State Street 1.05M $143.06M +4.1%
Conestoga Capital Advisors 1.01M $138.26M +1.1%
Dimensional Fund Advisors 653.35K $89.31M -2.0%
Geneva Capital Management 648.24K $88.61M -0.5%
Geode Capital Management 627.44K $85.77M +3.9%
Schroder Investment Management 570.41K $78.52M -5.4%
Largest transactions Shares Bought/sold Change
APG Asset Management US 0 -2.72M EXIT
Norges Bank 0 -296.65K EXIT
Vanguard 3.52M -222.26K -5.9%
Wasatch Advisors 1.5M -194.68K -11.5%
Brown Capital Management 501.98K -72.82K -12.7%
Assenagon Asset Management 156.26K +72.48K +86.5%
Nuveen Asset Management 132.67K -71.85K -35.1%
Renaissance Technologies 259.7K +63.5K +32.4%
TROW T. Rowe Price 212.38K +59.22K +38.7%
Lord, Abbett & Co. 337.2K -58.62K -14.8%

Financial report summary

?
Management Discussion
  • Item 7.        Management’s Discussion and Analysis of Financial Condition and Results of Operations
  • We develop, manufacture, distribute and market specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Our three reportable segments are strategic businesses that offer products and services to different markets: Human Nutrition & Health, Animal Nutrition &
  • Health, and Specialty Products, as more fully described in Note 11 of the consolidated financial statements. Sales and production of products outside of our reportable segments and other minor business activities are included in "Other and Unallocated".

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: advertising, America, assistance, broadly, build, Compact, conflict, consecutive, consulting, employed, energy, ESG, Europe, facing, February, foregoing, foster, Framework, fundamental, grew, harder, heart, hinder, instability, introduce, likelihood, live, macroeconomic, magazine, Maryland, military, newly, Newsweek, partnership, political, prescribed, presence, pressure, previously, proud, proudly, publicly, put, reliable, restocking, Russia, shape, smarter, social, Statista, strained, successfully, Sustainability, therewith, today, tomorrow, Ukraine, unable, upward, vision, volume
Removed: August, beneficial, capped, clarified, closely, cloud, codification, computing, consequential, controlled, covid, Deal, disclosed, distribution, eliminating, ending, evaluating, impairment, instrument, law, legislation, lower, modified, monitoring, noncancelable, passed, permitted, preparing, pronouncement, prospective, provision, relief, remained, remedy, repay, retained, retrospective, reviewed, River, round, Security, September, specific, sponsor, step, Test, testing

Patents

Utility
Compositions Comprising Choline
26 May 22
The present disclosure provides a single dose form composition to optimize the relationship between the ‘Tolate-Cobalamin’ and ‘Choline-Betaine’ pathways.
Utility
Iron supplement
17 May 22
An orally deliverable dosage system comprises (a) iron in a form of one or more physiologically acceptable iron grades, compounds and/or complexes; and (b) an agent to mitigate one or more gastrointestinal adverse effects of unabsorbed iron, said agent comprising one or both of a zinc component and a chelator component, said zinc component if present comprising one or more physiologically acceptable zinc compounds and/or complexes, and said chelator component if present comprising an ion-chelating compound formulated for release distal to the primary site of iron absorption in the duodenum.
Utility
Methods of Increasing Magnesium Bioavailability and Absorption
28 Apr 22
The present disclosure relates to compositions and methods of increasing magnesium bioavailability and absorption.
Utility
Compositions comprising choline
22 Mar 22
The present disclosure provides a single dose form composition to optimize the relationship between the ‘Folate-Cobalamin’ and ‘Choline-Betaine’ pathways.
Utility
Storage Stable Choline Chloride Compositions
3 Mar 22
The present disclosure encompasses a composition comprising three-dimensional shapes, wherein each shape consists essentially of choline chloride, and methods of making such three-dimensional shapes.